Hypophosphatemia (DBCOND0023801)

Identifiers

Synonyms

Decreased phosphate / Hypophosphataemia / Blood phosphorus decreased / Decrease in serum phosphorus / Decreased serum phosphorus / Reduction in phosphorus / Decreases in phosphorus / Reduced serum phosphorus / Decreased phosphorus / Phosphate decreased / Phosphate low / Hypophosphatemia (disorder)

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
1,6-Fructose Diphosphate (Linear Form)	A drug used to treat hypophosphataemia.	Fructose-bisphosphate aldolase Btarget Fructose-bisphosphate aldolase Atarget
Burosumab	A fibroblast growth factor 23 blocking antibody used to treat X-linked hypophosphatemia.	Fibroblast growth factor 23target
Calcium gluconate	An ingredient found in a variety of supplements and vitamins, and is used to lower potassium in the blood or treat magnesium poisoning.	No drug targets
Fosfructose	A phosphorylated form of fructose indicated in the treatment of hypophosphatemia.	No drug targets
Sodium phosphate, dibasic	An osmotic laxative used to cleanse the colon before a colonoscopy.	Sodium-dependent phosphate transporter 1transporter Sodium-dependent phosphate transporter 2transporter Sodium-dependent phosphate transport protein 2Atransporter Sodium-dependent phosphate transport protein 2Btransporter Sodium-dependent phosphate transport protein 2Ctransporter Carbonic anhydrase 4target
Sodium phosphate, monobasic	A source of phosphorus used prevent or correct hypophosphatemia in patients with restricted or no oral intake.	Sodium-dependent phosphate transporter 1transporter Sodium-dependent phosphate transporter 2transporter Sodium-dependent phosphate transport protein 2Atransporter Sodium-dependent phosphate transport protein 2Btransporter Sodium-dependent phosphate transport protein 2Ctransporter

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT01676844	Investigating a New Way of Giving Medicine to Newborn and Preterm Babies	Monopotassium phosphate	treatment	2	unknown_status
NCT04502784	Investigation of Hypophosphataemia Following Intravenous Iron	No drug interventions	Not Available	Not Available	unknown_status
NCT00688077	FGF-23 Suppressibility by Calcitonin	Salmon calcitonin	basic_science	Not Available	completed
NCT03771105	The Impact of Phosphate Metabolism on Healthy Aging	Phosphate ion	treatment	0	suspended
NCT00975000	Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients	Cinacalcet	treatment	3	completed
NCT05098249	Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia	No drug interventions	treatment	4	completed
NCT06112236	Effects of Treatments for Anemia and Iron Deficiency on the Electrolyte Balance in Lung Transplant Recipients: A Special Focus on Hypophosphatemia	No drug interventions	Not Available	Not Available	active_not_recruiting
NCT04519762	Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICU	Sodium glycerophosphate	diagnostic	4	unknown_status
NCT06344546	Metabolic Pathway Analysis in Intensive Care Unit Patients With Refeeding Syndrome	No drug interventions	Not Available	Not Available	not_yet_recruiting
NCT01011114	Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant	Cinacalcet	treatment	Not Available	terminated
NCT03740802	Hypophosphatemia as a Predictor in Surgical Resuscitation Sepsis	No drug interventions	Not Available	Not Available	completed
NCT03489993	FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)	No drug interventions	Not Available	Not Available	completed
NCT04814641	Hypophosphatemia and Bronchiolitis	No drug interventions	Not Available	Not Available	unknown_status
NCT03529058	Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU	No drug interventions	Not Available	Not Available	completed
NCT05909722	Validation of the GIDS and Description of Phosphate Disorders	No drug interventions	Not Available	Not Available	recruiting
NCT03581591	Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets	Burosumab	treatment	3	completed
NCT03976440	Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED: a Pilot Study	No drug interventions	Not Available	Not Available	unknown_status
NCT06350955	IV Iron-induced Hypophosphatemia After RYGB	Ferric carboxymaltose Iron	treatment	4	recruiting
NCT02837523	Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)	No drug interventions	Not Available	Not Available	withdrawn
NCT01660308	Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia	No drug interventions	Not Available	Not Available	unknown_status